Related Experiment Video

Updated: Aug 15, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas

Gregory M Sheehan1, Bhaskar V S Kallakury, Christine E Sheehan

  • 1Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA.

Human Pathology
|November 2, 2005
PubMed

Insights

Smad4 protein expression is variable in prostate cancer, with overexpression linked to aggressive tumor features like higher grade, stage, and abnormal DNA ploidy. Further research is needed to fully understand its role in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Smad4 (DPC4) is a tumor suppressor gene involved in TGF-beta signaling, crucial for suppressing epithelial cell growth.
  • Expression of Smad4 varies across cancers, with reported losses in some and increased expression in others.
  • There is a lack of consensus regarding Smad4 expression and its role in prostate cancer.

Purpose of the Study:

  • To assess Smad4 protein immunoreactivity in prostatic adenocarcinomas (PACs).
  • To correlate Smad4 expression with morphological and prognostic variables in PACs.
  • To investigate the potential role of Smad4 in prostate cancer progression.

Main Methods:

  • Immunohistochemistry was used to evaluate Smad4 nuclear and cytoplasmic expression in 133 PAC tissue sections.
  • Semiquantitative scoring assessed the intensity and percentage of positive cells for Smad4.
  • Deoxyribonucleic acid (DNA) ploidy analysis was performed using static image analysis on Feulgen-stained sections.

Main Results:

  • Variable Smad4 positivity was observed in adjacent benign glands.
  • Increased nuclear Smad4 expression was found in 48% of PACs, and increased cytoplasmic expression in 51%.
  • Nuclear and cytoplasmic Smad4 overexpression correlated with higher tumor grade, stage, and DNA ploidy, indicating aggressive behavior.

Conclusions:

  • Smad4 protein expression persists in PACs and is often overexpressed compared to benign glands.
  • Smad4 overexpression correlates with prognostic indicators of aggressive tumor behavior in prostate cancer.
  • Further studies are warranted to elucidate the precise role of Smad4 in prostate and other cancers due to its variable expression patterns.

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...